Clinical Trial: Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Smallpox
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label, Single-dose, Randomized, Two-period, Crossover Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adult Participants
Brief Summary:
The goal of this clinical trial is to evaluate whether both Form H and Form II, 100mg brincidofovir tablets are bioequivalent, when given under fasting conditions in healthy adults.Participants will be randomized to each receive one tablet of Form H and one tablet of Form II,14 days apart and undergo pharmacokinetic testing pre-dose and post-dose to evaluate safety.This is an open-label, single-dose, randomized, two-period, crossover study.
Read more